HOME >> BIOLOGY >> NEWS
MGH researchers first to identify genetic malfunction in type 1 diabetes

A research study from the Massachusetts General Hospital (MGH) has identified a gene malfunction that appears to be central to the development of type 1 diabetes. The study in a classic animal model of type 1 diabetes found that a gene required to help teach the immune system to recognize so-called "self" proteins is somehow inactivated, even though its sequence is not mutated. The scientists also found that the inactivation of this gene called Lmp2 has a profound impact on another key protein called nuclear factor kappa-B (NF-kB), a major controller of several immune system activities. Finding ways to correct or circumvent the malfunction identified in this study may lead to ways of preventing or stopping the autoimmune reaction at the heart of type 1 diabetes.

"This is a true genetic abnormality we can associate with type 1 diabetes," says Denise Faustman, MD, PhD, of the MGH Diabetes Unit, who led the study appearing in the December issue of Molecular and Cellular Biology. "While Lmp2 is located in a portion of the genome that had been linked to the disease, it hadn't been considered a candidate because its sequence is normal. But studying the gene's function has showed us a previously unsuspected problem: In the immune system cells we looked at, the Lmp2 protein virtually disappears by the time these mice reach a certain age, therefore most likely initiating their diabetes."

Type 1 diabetes (also called juvenile or insulin-dependent diabetes) is an autoimmune disease in which the immune system mistakenly attacks the insulin-producing beta cells of the pancreas. Normally, immune system components called T cells learn not to attack the body's own tissues through the action of MHC Class I molecules, which sit on the surface of B cells and macrophages. There the molecules display tiny bits of "self" proteins to the T cells, the immune system's killers, essentially teaching them to ignore the body's own tissues. Another kind of MHC molecule, cal
'"/>

Contact: Susan McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
23-Nov-1999


Page: 1 2 3

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/11/2019)... ... July 11, 2019 , ... Spartan ... a partnership with LiquiTech, a leader in Legionella prevention for the health ... integrate Spartan’s innovative environmental DNA testing platform to provide a new approach ...
(Date:7/9/2019)... ... 2019 , ... KMK Consulting, Inc. announced the ... expansion strengthens KMK’s presence for the sales, support, and delivery of commercial ... consulting for the biotechnology corridor. With this expansion, KMK can better meet the ...
(Date:6/27/2019)... ... June 27, 2019 , ... Lighting designers from integrated design ... (IES), which honored the designers for creating both engaging and energy efficient lighting systems. ... , an office tower in San Diego, California earned an IES Illumination Award of ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with ... upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. ... viewers about how its technology facilitates laboratories to improve efficiency and quality of ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally ... acquisition provides Object exclusive ownership and commercialization rights to a full spectrum of ...
Breaking Biology Technology:
Cached News: